back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-11-13 10:02 Tx date 2023-11-09 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$72,000
+400,000 vol $0.18 each |
400,000 | |
| Filed 2023-11-13 10:01 Tx date 2022-03-14 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-26 14:16 Tx date 2023-07-26 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,006
+133,385 vol $0.135 each |
1,033,385 | |
| Filed 2023-07-26 14:15 Tx date 2023-07-26 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
57 - Exercise of rights
|
$-18,006.975
-133,385 vol $0.135 each |
418,553 | |
| Filed 2023-05-09 18:13 Tx date 2023-05-04 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Holder: Deschamps Global Healthcare Commercialization Services LLC (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+2,473,333 vol |
2,473,333 | |
| Filed 2023-05-09 18:13 Tx date 2022-03-14 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Holder: Deschamps Global Healthcare Commercialization Services LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-09 18:13 Tx date 2023-05-04 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Holder: Deschamps Global Healthcare Commercialization Services LLC (Indirect Ownership)
|
Warrants May 4, 2023 ($0.35) 36mo.
16 - Acquisition or disposition under a prospectus exemption
|
$865,666
+2,473,333 vol $0.35 each |
2,473,333 | |
| Filed 2023-05-09 18:12 Tx date 2022-03-14 |
$CHGX
CHITOGENX INC |
Deschamps, Philippe
5 - Senior Officer of Issuer
Holder: Deschamps Global Healthcare Commercialization Services LLC (Indirect Ownership)
|
Warrants May 4, 2023 ($0.35) 36mo.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-26 15:37 Tx date 2022-04-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
56 - Grant of rights
|
$110,387
+551,938 vol $0.20 each |
551,938 | |
| Filed 2022-04-13 11:04 Tx date 2022-04-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
56 - Grant of rights
|
$93,000
+465,000 vol $0.20 each |
||
| Filed 2022-04-13 11:04 Tx date 2022-04-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
56 - Grant of rights
|
$93,000
+465,000 vol $0.20 each |
465,000 | |
| Filed 2022-04-13 11:01 Tx date 2022-03-14 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-13 11:00 Tx date 2022-04-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
2,000,000 | |
| Filed 2022-04-13 10:59 Tx date 2022-03-14 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 13:41 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants April 5, 2022 ($0.35) 24mo.
16 - Acquisition or disposition under a prospectus exemption
|
+900,000 vol |
900,000 | |
| Filed 2022-04-08 13:39 Tx date 2022-03-14 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants April 5, 2022 ($0.35) 24mo.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 13:39 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$180,000
+900,000 vol $0.20 each |
900,000 | |
| Filed 2022-04-08 13:36 Tx date 2022-03-14 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Deschamps, Philippe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-08 Tx date 2016-04-04 |
$HSM
Helius Medical Technologies, Inc. |
Deschamps, Philippe
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,167
+50,186 vol $0.90 each |
54,886 | |
| Filed 2016-07-20 Tx date 2016-07-13 |
$HSM
Helius Medical Technologies, Inc. |
Deschamps, Philippe
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,084,999
+1,500,000 vol $1.39 each |
3,300,000 |